(Q40749276)

23 September 2017

Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo (English)

1 reference

23 September 2017

1 reference

1 reference

Paul M Rogers

1

1 reference

23 September 2017

Philip J Beale

2

1 reference

23 September 2017

Mansour Al-Moundhri

3

1 reference

23 September 2017

Frances Boxall

4

1 reference

23 September 2017

Lisa Patterson

5

1 reference

23 September 2017

Melanie Valenti

6

1 reference

23 September 2017

Florence Raynaud

7

1 reference

23 September 2017

Steve Hobbs

8

1 reference

23 September 2017

Stephen Johnston

9

1 reference

23 September 2017

Lloyd R Kelland

10

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

International Journal of Cancer

23 September 2017

1 reference

23 September 2017

97

1 reference

23 September 2017

6

1 reference

23 September 2017

858-863

1 reference

Drug-target interactions: only the first step in the commitment to a programmed cell death?

23 September 2017

1 reference

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

Apoptosis in cancer therapy: crossing the threshold

21 January 2018

1 reference

The biochemistry of apoptosis

21 January 2018

1 reference

BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma

21 January 2018

1 reference

Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors

21 January 2018

1 reference

Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model

21 January 2018

1 reference

Genetic analysis of chemoresistance in primary murine lymphomas.

21 January 2018

1 reference

Expression and prognostic significance of Bcl-2 in ovarian tumours

21 January 2018

1 reference

In vivo veritas: Bcl-2 and Bcl-X(L)mediate tumor cell resistance to chemotherapy.

21 January 2018

1 reference

In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473

21 January 2018

1 reference

cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines

21 January 2018

1 reference

Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery

21 January 2018

1 reference

Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins

21 January 2018

1 reference

DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90

21 January 2018

1 reference

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

21 January 2018

1 reference

Bcl-x(L) forms an ion channel in synthetic lipid membranes.

21 January 2018

1 reference

BAX protein expression and clinical outcome in epithelial ovarian cancer.

21 January 2018

1 reference

Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis

21 January 2018

1 reference

bcl-2 over-expression delays radiation-induced apoptosis without affecting the clonogenic survival of human prostate cancer cells

21 January 2018

1 reference

Characterisation of the p53 status, BCL-2 expression and radiation and platinum drug sensitivity of a panel of human ovarian cancer cell lines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10132

1 reference

23 September 2017

1 reference